Skip to main content
Clinical Trials/CTRI/2019/05/019453
CTRI/2019/05/019453Not yet recruitingPhase 2/3

Evaluation of haemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in participants undergoing laproscopic appendicectomy:A prospective randomized parallel group double blind clinical trial.

Government medical college Bhavnagar1 site in 1 country80 target enrollmentStarted: March 6, 2019Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Enrollment
80
Locations
1
Primary Endpoint
1)Time of onset of action

Study Overview

Brief Summary

Neuromuscular blocking agents (NBM’S) both depolarizing and non depolarizing are routinely used to facilitate tracheal intubation during induction of anaesthesia and to maintain satisfactory muscle relaxation during surgery.

Atracurium, a non depolarizing muscle relexant with an intermediate duration of action is independent of hepatic and renal functions to terminate its action and had minimal side effects but it also shows weak histamine releasing properties which contribute to many of its cardiovascular side effects.

Thus newer agent cis-atracurium has no histamine releasing properties, greater haemodynemic stability, hoffmann degradation so elimination of drug is independent of hepatic and renal failure.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Double Blind Double Dummy

Eligibility Criteria

Ages
18.00 Year(s) to 50.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Informed written consent 2)18 to 50 years of age 3)Patient is of either gender 4)ASA physical status I and II 5)Undergoing elective laproscopic appendicectomy 6)Requiring endotracheal intubation.

Exclusion Criteria

  • Refusing to give consent 2)Anticipated difficult airway 3)Pre existing liver or renal failure 4)Therapy with drug known to interfere with neuromuscular transmission 5)Antenatal and lactating females 6)Prolonged preoperative bed rest 7)Patient having neuromuscular disorders 8)ASA physical status III and IV.

Outcomes

Primary Outcomes

1)Time of onset of action

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

2)Intubation time

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

3)Time interval between loading and first maintenance dose

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

4)Time interval between maintenance doses

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

5)Extubation time

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

6)Total number of doses required

Time Frame: 1)Noted when TOF count is reduced to 3 on PNS afer giving loading dose | 2)Noted when no response to TOF on PNS after giving loading dose | 3)Noted when TOF count is more than 2 on PNS after giving loading dose | 4)Noted when TOF count is more than 2 on PNS after giving top up dose of drug | 5)Noted from end of the operation to extubation and TOF count is 4 on PNS

Secondary Outcomes

  • Haemodynamic effects( pulse, non invasive blood pressure monitoring)(Baseline)

Investigators

Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials